Loading...
Integrated Diagnostics Holdings plc
IDHC.L•LSE
HealthcareMedical - Diagnostics & Research
$0.36
$0.01(2.86%)
Integrated Diagnostics Holdings plc (IDHC.L) Stock Overview
Explore Integrated Diagnostics Holdings plc’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for IDHC.LStats details for IDHC.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for IDHC.LAnalyst Recommendations details for IDHC.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
CEO
Dr. Hend El Sherbini Ph.D.
Employees
6,309
Headquarters
12 Castle Street, Saint Helier
Founded
2015